125 related articles for article (PubMed ID: 3091830)
1. Selective thromboxane synthetase inhibitors. 4. 2-(1H-imidazol-1-ylmethyl) carboxylic acids of benzo[b]furan, benzo[b]thiophene, indole, and naphthalene.
Cross PE; Dickinson RP; Parry MJ; Randall MJ
J Med Chem; 1986 Sep; 29(9):1643-50. PubMed ID: 3091830
[TBL] [Abstract][Full Text] [Related]
2. Selective thromboxane synthetase inhibitors. 3. 1H-imidazol-1-yl-substituted benzo[b]furan-, benzo[b]thiophene-, and indole-2- and -3-carboxylic acids.
Cross PE; Dickinson RP; Parry MJ; Randall MJ
J Med Chem; 1986 Sep; 29(9):1637-43. PubMed ID: 3746813
[TBL] [Abstract][Full Text] [Related]
3. Selective thromboxane synthetase inhibitors. 2. 3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogues.
Cross PE; Dickinson RP; Parry MJ; Randall MJ
J Med Chem; 1986 Mar; 29(3):342-6. PubMed ID: 3081722
[TBL] [Abstract][Full Text] [Related]
4. Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazoles.
Cross PE; Dickinson RP; Parry MJ; Randall MJ
J Med Chem; 1985 Oct; 28(10):1427-32. PubMed ID: 3930740
[TBL] [Abstract][Full Text] [Related]
5. 3-(1-imidazolylmethyl) indoles: potent and selective inhibitors of human blood platelet thromboxane synthetase.
Cross PE; Dickinson RP; Parry MJ; Randall MJ
Agents Actions; 1981 May; 11(3):274-80. PubMed ID: 7020379
[TBL] [Abstract][Full Text] [Related]
6. CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben.
Olson RW; Cohen DS; Ku EC; Kimble EF; Renfroe HB; Smith EF
Eur J Pharmacol; 1987 Jan; 133(3):265-73. PubMed ID: 3104066
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane A2 synthetase inhibitors with histamine H1-blocking activity: synthesis and evaluation of a new series of indole derivatives.
Kamiya S; Matsui H; Shirahase H; Nakamura S; Wada K; Kanda M; Shimaji H; Kakeya N
Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1692-5. PubMed ID: 8536342
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane synthetase inhibitors and antihypertensive agents. 3. N-[(1H-imidazol-1-yl)alkyl]heteroaryl amides as potent enzyme inhibitors.
Press JB; Wright WB; Chan PS; Haug MF; Marsico JW; Tomcufcik AS
J Med Chem; 1987 Jun; 30(6):1036-40. PubMed ID: 3585902
[TBL] [Abstract][Full Text] [Related]
9. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R
J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586
[TBL] [Abstract][Full Text] [Related]
10. RS-5186, a novel thromboxane synthetase inhibitor with a potent and extended duration of action.
Ushiyama S; Ito T; Asai F; Oshima T; Terada A; Matsuda K; Yamazaki M
Thromb Res; 1988 Sep; 51(5):507-20. PubMed ID: 3175990
[TBL] [Abstract][Full Text] [Related]
11. Effects of 1-[3-(4-benzhydryl-1-piperazinyl)propyl]-3- (1H-imidazol-1-ylmethyl)-1H-indole-6-carboxylic acid with thromboxane A2 synthetase inhibitory and H1-blocking activities on anaphylactic bronchospasm.
Nakamura S; Shirahase H; Kanda M; Wada K; Kamiya S; Matsui H; Kurahashi K
Arzneimittelforschung; 1996 Nov; 46(11):1067-71. PubMed ID: 8955866
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of thromboxane and 12-HPETE formation by dazoxiben and its two thiophenic acid-substituted derivatives.
Smith EF; Darius H; Ferber H; Schrör K
Eur J Pharmacol; 1985 Jun; 112(2):161-9. PubMed ID: 3896821
[TBL] [Abstract][Full Text] [Related]
13. [(1H-imidazol-1-yl)methyl]- and [(3-pyridinyl)methyl]pyrroles as thromboxane synthetase inhibitors.
Martinez GR; Walker KA; Hirschfeld DR; Maloney PJ; Yang DS; Rosenkranz RP
J Med Chem; 1989 Apr; 32(4):890-7. PubMed ID: 2704033
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 synthase inhibitors. 5-(3-Pyridylmethyl)benzofuran-2-carboxylic acids.
Johnson RA; Nidy EG; Aiken JW; Crittenden NJ; Gorman RR
J Med Chem; 1986 Aug; 29(8):1461-8. PubMed ID: 3735314
[TBL] [Abstract][Full Text] [Related]
15. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW
J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane synthetase inhibitors and antihypertensive agents. 2. N-[(1H-imidazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones and N-[(1H-1,2,4-triazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones as unique antihypertensive agents.
Press JB; Wright WB; Chan PS; Marsico JW; Haug MF; Tauber J; Tomcufcik AS
J Med Chem; 1986 May; 29(5):816-9. PubMed ID: 3517332
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane A2 synthetase inhibitors. 2. Syntheses and activities of tetrahydronaphthalene and indan derivatives.
Kanao M; Watanabe Y; Kimura Y; Saegusa J; Yamamoto K; Kanno H; Kanaya N; Kubo H; Ashida S; Ishikawa F
J Med Chem; 1989 Jun; 32(6):1326-34. PubMed ID: 2724303
[TBL] [Abstract][Full Text] [Related]
18. 1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthase and aromatase.
Jacobs C; Frotscher M; Dannhardt G; Hartmann RW
J Med Chem; 2000 May; 43(9):1841-51. PubMed ID: 10794700
[TBL] [Abstract][Full Text] [Related]
19. 7-Aroyl-2,3-dihydrobenzo[b]furan-3-carboxylic acids and 7-benzoyl-2,3-dihydrobenzo[b]thiophene-3-carboxylic acids as analgesic agents.
Boyle EA; Mangan FR; Markwell RE; Smith SA; Thomson MJ; Ward RW; Wyman PA
J Med Chem; 1986 Jun; 29(6):894-8. PubMed ID: 3086559
[TBL] [Abstract][Full Text] [Related]
20. In vitro antiplatelet profiles of the new thromboxane synthetase inhibitor sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate.
Asai F; Ito T; Ushiyama S; Matsuda K; Oshima T
Arzneimittelforschung; 1991 May; 41(5):506-10. PubMed ID: 1898421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]